1. Home
  2. APGE
  3. APGE News

Latest Apogee Therapeutics Inc. (APGE) News on January 19, 2025

This Apogee Therapeutics Insider Increased Their Holding In The Last Year
APGE

Simply Wall St.

25 days ago

This Apogee Therapeutics Insider Increased Their Holding In The Last Year

APGE

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 12/17/2024

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions
APGE

GlobeNewswire

a month ago

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions

Apogee Therapeutics Advances in I&I Disease Treatments
APGE

TipRanks

2 months ago

Apogee Therapeutics Advances in I&I Disease Treatments

APGE

MT Newswires

2 months ago

Wedbush Adjusts Price Target on Apogee Therapeutics to $90 From $87, Maintains Outperform Rating

Apogee Therapeutics Highlights Progress and Best-in-Class Potential of Novel Biologic Programs for I&I Diseases at 2024 Inaugural R&D Day
APGE

GlobeNewswire

2 months ago

Apogee Therapeutics Highlights Progress and Best-in-Class Potential of Novel Biologic Programs for I&I Diseases at 2024 Inaugural R&D Day

Apogee Therapeutics Announces Agenda for Virtual R&D Day
APGE

GlobeNewswire

2 months ago

Apogee Therapeutics Announces Agenda for Virtual R&D Day

APGE

MT Newswires

2 months ago

Canaccord Genuity Initiates Apogee Therapeutics at Buy With $89 Price Target

Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
APGE

GlobeNewswire

2 months ago

Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans
APGE

Simply Wall St.

2 months ago

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans

Apogee reports Q3 EPS, expects cash to fund operations into Q1 of 2028
APGE

TipRanks

2 months ago

Apogee reports Q3 EPS, expects cash to fund operations into Q1 of 2028

APGE

MT Newswires

2 months ago

Apogee Therapeutics' Q3 Net Loss Widens

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
APGE

GlobeNewswire

2 months ago

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results

Apogee Therapeutics to Participate in Upcoming November Investor Conferences
APGE

GlobeNewswire

2 months ago

Apogee Therapeutics to Participate in Upcoming November Investor Conferences

Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases
APGE

GlobeNewswire

3 months ago

Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases

Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
APGE

GlobeNewswire

3 months ago

Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting

Apogee Therapeutics, Inc. (APGE): A Hot Stock to Buy Now
APGE

Insider Monkey

3 months ago

Apogee Therapeutics, Inc. (APGE): A Hot Stock to Buy Now

APGE

MT Newswires

3 months ago

Apogee Therapeutics Insider Sold Shares Worth $2,249,307, According to a Recent SEC Filing

Wellington Management Group LLP Increases Stake in Apogee Therapeutics Inc
APGE

GuruFocus.com

3 months ago

Wellington Management Group LLP Increases Stake in Apogee Therapeutics Inc

Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
APGE

GlobeNewswire

4 months ago

Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit

Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
APGE

GlobeNewswire

4 months ago

Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer

APGE

MT Newswires

4 months ago

Apogee Therapeutics Insider Sold Shares Worth $1,904,841, According to a Recent SEC Filing

Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
APGE

GuruFocus.com

4 months ago

Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)

Insider Sale: CFO Jane Henderson Sells 6,000 Shares of Apogee Therapeutics Inc (APGE)
APGE

GuruFocus.com

5 months ago

Insider Sale: CFO Jane Henderson Sells 6,000 Shares of Apogee Therapeutics Inc (APGE)

APGE

MT Newswires

5 months ago

Apogee Therapeutics Begins Dosing Volunteers in Phase 1 Atopic Dermatitis Trial

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
APGE

GlobeNewswire

5 months ago

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases

APGE

MT Newswires

5 months ago

Apogee Therapeutics' Q2 Net Loss Widens

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
APGE

GlobeNewswire

5 months ago

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results

APGE

MT Newswires

5 months ago

Apogee Therapeutics Insider Sold Shares Worth $1,624,764, According to a Recent SEC Filing

Apogee Therapeutics Inc (APGE) CEO Michael Henderson Sells 40,000 Shares
APGE

GuruFocus.com

5 months ago

Apogee Therapeutics Inc (APGE) CEO Michael Henderson Sells 40,000 Shares

Insider Sale: Carl Dambkowski Sells 7,335 Shares of Apogee Therapeutics Inc (APGE)
APGE

GuruFocus.com

5 months ago

Insider Sale: Carl Dambkowski Sells 7,335 Shares of Apogee Therapeutics Inc (APGE)

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
APGE

GlobeNewswire

6 months ago

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

Insider Sale: CEO Michael Henderson Sells 15,000 Shares of Apogee Therapeutics Inc (APGE)
APGE

GuruFocus.com

6 months ago

Insider Sale: CEO Michael Henderson Sells 15,000 Shares of Apogee Therapeutics Inc (APGE)

Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
APGE

GuruFocus.com

6 months ago

Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)

Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event
APGE

Investor's Business Daily

7 months ago

Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event

Can DocuSign's AI offering accelerate growth?
APGE

Yahoo Finance Video

7 months ago

Can DocuSign's AI offering accelerate growth?

Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization
APGE

GlobeNewswire

7 months ago

Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization

Analysis-Mexico investors worry lopsided vote could threaten rule of law
APGE

Reuters

7 months ago

Analysis-Mexico investors worry lopsided vote could threaten rule of law

AI Boom Giving Taiwan Semiconductor Sales A Boost
APGE

Investor's Business Daily

7 months ago

AI Boom Giving Taiwan Semiconductor Sales A Boost

Smart Irrigation Market worth $3.0 billion by 2029 - Exclusive Report by MarketsandMarkets™
APGE

PR Newswire

7 months ago

Smart Irrigation Market worth $3.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

APGE

Business Wire

7 months ago

Airstar Bank, with AMTD as a co-founder, successfully introduces Futu as A New Shareholder

Taxes Served Corp. Acquires Blue Mountain Bookkeeping LLC to Enhance Tax and Bookkeeping Services
APGE

PR Newswire

7 months ago

Taxes Served Corp. Acquires Blue Mountain Bookkeeping LLC to Enhance Tax and Bookkeeping Services

Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
APGE

GlobeNewswire

8 months ago

Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation
APGE

Simply Wall St.

8 months ago

Here's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Situation

Apogee Therapeutics to Participate in Upcoming June Investor Conferences
APGE

GlobeNewswire

8 months ago

Apogee Therapeutics to Participate in Upcoming June Investor Conferences

Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
APGE

GlobeNewswire

8 months ago

Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases

APGE

MT Newswires

8 months ago

Apogee Therapeutics' Q1 Net Loss Widens

Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
APGE

GlobeNewswire

8 months ago

Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results

APGE

MT Newswires

8 months ago

BofA Securities Starts Coverage on Apogee Therapeutics With Buy Rating, $80 Price Target

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
APGE

GlobeNewswire

8 months ago

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference

With 54% institutional ownership, Apogee Therapeutics, Inc. (NASDAQ:APGE) is a favorite amongst the big guns
APGE

Simply Wall St.

9 months ago

With 54% institutional ownership, Apogee Therapeutics, Inc. (NASDAQ:APGE) is a favorite amongst the big guns

Paragon’s hub-and-spoke biotech model yields another reverse merger
APGE

BioPharma Dive

10 months ago

Paragon’s hub-and-spoke biotech model yields another reverse merger

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
APGE

Zacks

10 months ago

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
APGE

GlobeNewswire

10 months ago

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
APGE

GlobeNewswire

10 months ago

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
APGE

GlobeNewswire

10 months ago

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering

Insiders Of Apogee Therapeutics Reap Rewards After Their Investment Jumps Another US$74m
APGE

Simply Wall St.

10 months ago

Insiders Of Apogee Therapeutics Reap Rewards After Their Investment Jumps Another US$74m

Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
APGE

GlobeNewswire

10 months ago

Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering

Apogee Catapults 42% After Eczema Drug Blows Expectations Out Of The Water
APGE

Investor's Business Daily

10 months ago

Apogee Catapults 42% After Eczema Drug Blows Expectations Out Of The Water

IPO Stock Apogee Rockets On Solid Phase 1 Outcome
APGE

Investor's Business Daily

10 months ago

IPO Stock Apogee Rockets On Solid Phase 1 Outcome

Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
APGE

GlobeNewswire

10 months ago

Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule with Half-Life of Approximately 75 Days
APGE

GlobeNewswire

10 months ago

Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Schedule with Half-Life of Approximately 75 Days

Apogee data hint at potential for long-lasting eczema drug
APGE

BioPharma Dive

10 months ago

Apogee data hint at potential for long-lasting eczema drug

Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024
APGE

GlobeNewswire

10 months ago

Apogee to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases on March 5, 2024

Estimating The Fair Value Of Agilysys, Inc. (NASDAQ:AGYS)
APGE

Simply Wall St.

a year ago

Estimating The Fair Value Of Agilysys, Inc. (NASDAQ:AGYS)

Granite Unveils State-of-the-Art Aggregate Plant
APGE

Business Wire

a year ago

Granite Unveils State-of-the-Art Aggregate Plant

PTC (PTC) Q1 Earnings: What To Expect
APGE

StockStory

a year ago

PTC (PTC) Q1 Earnings: What To Expect

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
APGE

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

PacWest Bancorp (NASDAQ:PACW) Q4 2023 Earnings Call Transcript
APGE

Insider Monkey

a year ago

PacWest Bancorp (NASDAQ:PACW) Q4 2023 Earnings Call Transcript

Why Bloomin' Brands, Inc. (NASDAQ:BLMN) Could Be Worth Watching
APGE

Simply Wall St.

a year ago

Why Bloomin' Brands, Inc. (NASDAQ:BLMN) Could Be Worth Watching

Cushman & Wakefield Elevates Sustainability Solutions with Measurabl
APGE

Business Wire

a year ago

Cushman & Wakefield Elevates Sustainability Solutions with Measurabl

BankUnited, Inc. (BKU) Matches Q4 Earnings Estimates
APGE

Zacks

a year ago

BankUnited, Inc. (BKU) Matches Q4 Earnings Estimates

APGE

Thomson Reuters StreetEvents

a year ago

Q4 2023 Associated Banc-Corp Earnings Call

Remitly Global Inc CEO Matthew Oppenheimer Sells 20,832 Shares
APGE

GuruFocus.com

a year ago

Remitly Global Inc CEO Matthew Oppenheimer Sells 20,832 Shares

Associated Banc-Corp (ASB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
APGE

Zacks

a year ago

Associated Banc-Corp (ASB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

APGE

ACCESSWIRE

a year ago

HSN Champions Emerging Designers Through Exclusive Collaboration With Harlem's Fashion Row

ETRN vs. WHD: Which Stock Should Value Investors Buy Now?
APGE

Zacks

a year ago

ETRN vs. WHD: Which Stock Should Value Investors Buy Now?

OSI Systems Inc (OSIS) Posts Record Q2 Revenues and Earnings, Raises FY 2024 Guidance
APGE

GuruFocus.com

a year ago

OSI Systems Inc (OSIS) Posts Record Q2 Revenues and Earnings, Raises FY 2024 Guidance

APGE

Associated Press Finance

a year ago

OSI: Fiscal Q2 Earnings Snapshot

APGE

Business Wire

a year ago

OSI Systems Reports Fiscal 2024 Second Quarter Financial Results

Eco Material Technologies and Alabama Power to Repurpose Coal Ash at Plant Barry
APGE

PR Newswire

a year ago

Eco Material Technologies and Alabama Power to Repurpose Coal Ash at Plant Barry

Unpacking Q3 Earnings: Colgate-Palmolive (NYSE:CL) In The Context Of Other Household Products Stocks
APGE

StockStory

a year ago

Unpacking Q3 Earnings: Colgate-Palmolive (NYSE:CL) In The Context Of Other Household Products Stocks

Analysts Estimate Methanex (MEOH) to Report a Decline in Earnings: What to Look Out for
APGE

Zacks

a year ago

Analysts Estimate Methanex (MEOH) to Report a Decline in Earnings: What to Look Out for

Granite Construction (GVA) Upgraded to Strong Buy: Here's Why
APGE

Zacks

a year ago

Granite Construction (GVA) Upgraded to Strong Buy: Here's Why

People Think Peloton Makes Money Selling Exercise Equipment, But 70% of Its Revenue Comes From Something Else Entirely
APGE

Motley Fool

a year ago

People Think Peloton Makes Money Selling Exercise Equipment, But 70% of Its Revenue Comes From Something Else Entirely

Qurate Retail, Inc. Announces Fourth Quarter Earnings Release and Conference Call
APGE

Business Wire

a year ago

Qurate Retail, Inc. Announces Fourth Quarter Earnings Release and Conference Call

APGE

GlobeNewswire

a year ago

ESCO Technologies Announces First Quarter 2024 Earnings Release and Conference Call

Papa John's International (NASDAQ:PZZA) jumps 3.4% this week, though earnings growth is still tracking behind five-year shareholder returns
APGE

Simply Wall St.

a year ago

Papa John's International (NASDAQ:PZZA) jumps 3.4% this week, though earnings growth is still tracking behind five-year shareholder returns

Travel + Leisure Co. to Report Fourth Quarter and Full-Year 2023 Financial Results on February 21, 2024
APGE

Business Wire

a year ago

Travel + Leisure Co. to Report Fourth Quarter and Full-Year 2023 Financial Results on February 21, 2024

Russell 2000 Stocks: Small Cap Chipmaker, Two Biotechs Jet Higher in Early Trade
APGE

Investor's Business Daily

a year ago

Russell 2000 Stocks: Small Cap Chipmaker, Two Biotechs Jet Higher in Early Trade

Construction Partners, Inc. Announces Schedule for Fiscal 2024 First Quarter Earnings Release and Conference Call
APGE

PR Newswire

a year ago

Construction Partners, Inc. Announces Schedule for Fiscal 2024 First Quarter Earnings Release and Conference Call

Kratos Defense & Security Solutions to Leverage the Most Advanced Metal Additive Manufacturing Solution Available With the Purchase of a Velo3D Sapphire Printer
APGE

Business Wire

a year ago

Kratos Defense & Security Solutions to Leverage the Most Advanced Metal Additive Manufacturing Solution Available With the Purchase of a Velo3D Sapphire Printer

Should You Think About Buying Schrödinger, Inc. (NASDAQ:SDGR) Now?
APGE

Simply Wall St.

a year ago

Should You Think About Buying Schrödinger, Inc. (NASDAQ:SDGR) Now?

3 High-Yield Stocks to Buy for 2024 and Beyond
APGE

Motley Fool

a year ago

3 High-Yield Stocks to Buy for 2024 and Beyond

APGE

Business Wire

a year ago

Sixth Street Specialty Lending, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results

Week’s Best: Vanguard Expands Savings Accounts
APGE

Barrons.com

a year ago

Week’s Best: Vanguard Expands Savings Accounts

ACV to Showcase the Future of Vehicle Sourcing and Inventory Management at the 2024 National Automobile Dealers Association Show in Las Vegas
APGE

GlobeNewswire

a year ago

ACV to Showcase the Future of Vehicle Sourcing and Inventory Management at the 2024 National Automobile Dealers Association Show in Las Vegas

Construction Partners' (NASDAQ:ROAD) investors will be pleased with their solid 280% return over the last five years
APGE

Simply Wall St.

a year ago

Construction Partners' (NASDAQ:ROAD) investors will be pleased with their solid 280% return over the last five years

Werner Enterprises Names Nathan Meisgeier as President
APGE

Business Wire

a year ago

Werner Enterprises Names Nathan Meisgeier as President

Does Bloomin' Brands (NASDAQ:BLMN) Deserve A Spot On Your Watchlist?
APGE

Simply Wall St.

a year ago

Does Bloomin' Brands (NASDAQ:BLMN) Deserve A Spot On Your Watchlist?

Share on Social Networks: